предыдущий|следующий

Исследования применения ягод годжи и их составных компонентов в заболеваниях центральной нервной системы

  • role： First author第一作者
  • Affiliation：

    Graduate School， Heilongjiang University of Chinese Medicine， Harbin 150040， China

  • Email：cc194373171@163.com
  • Introduction：程汝阳，在读硕士，从事中药药性理论及药效物质基础研究，E-mail：cc194373171@163.com
CHENG Ruyang1,  
  • Affiliation：

    Graduate School， Heilongjiang University of Chinese Medicine， Harbin 150040， China

SONG Weining1,  
  • Affiliation：

    Graduate School， Heilongjiang University of Chinese Medicine， Harbin 150040， China

JIANG Xin1,  
  • Affiliation：

    Graduate School， Heilongjiang University of Chinese Medicine， Harbin 150040， China

WANG Yehao1,  
  • Affiliation：

    Graduate School， Heilongjiang University of Chinese Medicine， Harbin 150040， China

ZHANG Chi1,  
  • Affiliation：

    Graduate School， Heilongjiang University of Chinese Medicine， Harbin 150040， China

ZHANG Zhendong1,  
  • role： Corresponding author通信作者
  • Affiliation：

    Research Institute of Chinese Medicine， Heilongjiang University of Chinese Medicine， Harbin 150040， China

  • Email：keji-liu@163.com
  • Introduction：刘树民，教授，从事中药药性理论及药效物质基础研究，E-mail：keji-liu@163.com
LIU Shumin2*

реферат

Механизмы возникновения заболеваний центральной нервной системы довольно сложны, серьезно影响я на психическое и физическое здоровье пациентов и создавая значительное экономическое бремя для общества. Западные лекарства для лечения заболеваний центральной нервной системы имеют ограниченную эффективность и сопровождаются многими побочными эффектами и противопоказаниями к применению. Традиционные китайские лекарственные травы, такие как ягоды годжи, обладают свойствами регуляции иммунитета, усиления кроветворной функции организма, защиты печени, противоопухолевым, гипогликемическим, жаропонижающим, а также замедляющим старение и противорадиационным действием, постепенно применяются в клинической практике. В последние годы активные компоненты ягод годжи привлекают внимание в лечении заболеваний центральной нервной системы. Исследования показывают, что активные компоненты ягод годжи могут оказывать потенциальную защиту центральной нервной системы за счет противовоспалительного, антиоксидантного действия, подавления апоптоза нейронов и восстановления повреждений нейронов, обладая характеристиками мультицелей и многонаправленных путей влияния. Данная статья суммирует терапевтическое воздействие активных компонентов ягод годжи на заболевания центральной нервной системы за последние десять лет, изучая базы данных PubMed, CNKI и Wanfang, с целью предоставить новые терапевтические подходы и идеи для исследования ягод годжи в заболеваниях центральной нервной системы.

ключеви́че слова́

ягоды годжи; полисахариды годжи; составные компоненты; нейродегенеративные заболевания; центральная нервная система

References

  1. 1.
    BIGBEE J W.Cells of the central nervous system：An overview of their structure and function［J］.Adv Neurobiol，2023，29：41-64.
  2. 2.
    XUE J，MA W，XU S Y，et al.Research progress on treatment of central nervous system diseases with active ingredients of Paeoniae Radix Rubra［J］.Chin Tradit Herb Drugs，2024，55（19）：6806-6819.
  3. 3.
    WANG Q，KONG D Z，ZHANG W，et al.Research progress of Chinese medicine in treatment of central nervous system diseases through blood-brain barrier［J］.Chin J Integr Tradit West Med，2024，44（8）：1013-1018.
  4. 4.
    WANG L，WU L E，JIA J X，et al.Pharmacological effects of roucongrong（Cistanches Herba） and its research progress in central nervous system diseases［J］.Chin J Tradit Chin Med，2024，42（3）：50-54.
  5. 5.
    ZHANG Y X.Interpretation of "Shennong's Classic of Materia Medica"（50）［J］.Kai Juan You Yi - Qiu Yi Wen Yao，2017，37（2）：50-51.
  6. 6.
    LI S Z.Bencao Gangmu［M］.Beijing：People's Medical Publishing House，2023：880.
  7. 7.
    LUO Q，JIN H Y，YANG J B，et al.Research progress on the therapeutic effects，clinical applications and modern pharmacological actions of Lycium barbarum L.Berries［J］.Drug Evaluation Res，2024，47（10）：2427-2433.
  8. 8.
    ZHOU Z Q.Research on the active components of Lycium barbarum against Alzheimer's disease［D］.Gangzhou：Jinan University，2016.
  9. 9.
    ZHANG Y H，SHEN Y.Potential mechanism of Lycii Fructus in the treatment of stroke based on network pharmacology［J］.Strait Pharm J，2023，35（12）：12-17.
  10. 10.
    SONG H J，ZHANG Q L，CUI Z J，et al.Research progress on chemical constituents and pharmacological effects of Lycii Fructus and its quality marker prediction and analysis［J］.West China J Pharm Sci，2022，37（2）：206-213.
  11. 11.
    TIAN X J，LIANG T S，LIU Y L，et al.Extraction，structural characterization，and biological functions of Lycium barbarum polysaccharides：A review［J］.Biomolecules，2019，doi：.
  12. 12.
    CHEN L，DUAN A Y，LI Y J，et al.Research progress on biological activity and application of Lycium barbarum polysaccharide［J］. Sci Technol Food Ind，2025，doi： .
  13. 13.
    WANG S L，ZAI Q Y，CHEN H G，et al.Comparison on biological activities of Lycium barbarum polysaccharides extracted with five methods［J］.China J Chin Mater Med，2024，49（1）：110-122.
  14. 14.
    LIU X.Based on the Nrf2/HO-1 signaling pathway probe the protective effect and mechanism of Lycium barbarum glycopeptide on retinal injury in rats with acute ocular hypertension［D］.Chengdu：Chengdu Univ Tradit Chin Med，2022.
  15. 15.
    YANG T T，HU Y H，YAN Y M，et al.Characterization and evaluation of antioxidant and anti-inflammatory activities of flavonoids from the fruits of Lycium barbarum［J］.Foods，2022，11（3）：306.
  16. 16.
    SONG W N，ZHANG S X，LU F，et al.Active components of Salviae Miltiorrhizae Radix et Rhizoma and its compound in treatment of nervous system diseases：A review［J］.Chin J Exp Tradit Med Form，2025，31（2）：303-313.
  17. 17.
    WU J X，CHEN T，WAN F Q，et al.Structural characterization of a polysaccharide from Lycium barbarum and its neuroprotective effect against β-amyloid peptide neurotoxicity［J］.Int J Biol Macromol，2021，176：352-363.
  18. 18.
    ZHOU Y，DUAN Y H，HUANG S C，et al.Polysaccharides from Lycium barbarum ameliorate amyloid pathology and cognitive functions in APP/PS1 transgenic mice［J］.Int J Biol Macromol，2020，144：1004-1012.
  19. 19.
    HE Y X，WANG Y Y，LI X，et al.Lycium barbarum polysaccharides improves cognitive functions in ICV-STZ-induced Alzheimer's disease mice model by improving the Synaptic structural plasticity and regulating IRS1/PI3K/Akt signaling pathway［J］.Neuro Molecular Med，2024，26（1）：15.
  20. 20.
    LIU X R.Effects of Lycium barbarum polysaccharides on Aβ42-induced oxidative damage in SH-SY5Y cells and lipopolysaccharide induced inflammatory in BV2 cells［D］.Yinchuan：Ningxia University，2018.
  21. 21.
    WANG X H，PANG L，ZHANG Y Q，et al.Lycium barbarum polysaccharide promotes nigrostriatal dopamine function by modulating PTEN/Akt/mTOR pathway in a methyl-4-phenyl-1，2，3，6-tetrahydropyridine （MPTP） murine model of Parkinson's disease［J］.Neurochem Res，2018，43（4）：938-947.
  22. 22.
    GAO K，LIU M Y，CAO J Y，et al.Protective effects of Lycium barbarum polysaccharide on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway［J］.Molecules，2014，20（1）：293-308.
  23. 23.
    CHEN H，ZHANG H J，SHI L，et al.Antioxidative and neuroprotective effects of Lycium barbarum polysaccharide on Parkinson's disease mice［J］.Chin J Nerv Ment Dis，2018，44（10）：613-618.
  24. 24.
    SONG J B，LIU L，LI Z Q，et al.Lycium barbarum polysaccharide improves dopamine metabolism and symptoms in an MPTP-induced model of Parkinson's disease［J］.BMC Med，2022，20（1）：412.
  25. 25.
    ZHENG J M，LUO Z H，CHIU K，et al.Lycium barbarum glycopetide prolong lifespan and alleviate Parkinson's disease in Caenorhabditis elegans［J］.Front Aging Neurosci，2023，15：1156265.doi：.
  26. 26.
    MA L，ZUO D，ZHANG C，et al.Protective effects of Lycium barbarum polysaccharides on epilepsy in rat hippocampal cell model and its mechanism［J］.Chin New Drugs J，2020，29（23）：2738-2743.
  27. 27.
    LI M J.Lycium barbarum polysaccharide exerts antidepressant effect by regulating gut microbiota［D］.Chengdu：Chengdu Univ Tradit Chin Med，2013.
  28. 28.
    ZHANG E D，YAU S Y，LAU B W M，et al.Synaptic plasticity，but not hippocampal neurogenesis，mediated the counteractive effect of wolfberry on depression in rats（1）［J］.Cell Transplant，2012，21（12）：2635-2649.
  29. 29.
    DAI Y L，GUO J X，ZHANG B R，et al.Lycium barbarum（wolfberry） glycopeptide prevents stress-induced anxiety disorders by regulating oxidative stress and ferroptosis in the medial prefrontal cortex［J］.Phytomedicine，2023，116：154864.
  30. 30.
    GE J P，LU H J，SONG X J，et al.Protective effects of LBP on cerebral ischemia reperfusion injury in mice and mechanism of inhibiting NF-κB，TNF-α，IL-6 and IL-1β［J］.Chin J Chin Mater Med，2017，42（2）：326-331.
  31. 31.
    ZHAO P，ZHOU R，ZHU X Y，et al.Neuroprotective effects of Lycium barbarum polysaccharide on focal cerebral ischemic injury in mice［J］.Neurochem Res，2017，42（10）：2798-2813.
  32. 32.
    LI X Y，PAN Y T，LI Y H，et al.Neuroprotective effect and its mechanism of Lycium barbarum polysaccharide on cerebral ischemia-reperfusion injury in mice［J］.Chin J Clin Pharmacol，2017，33（20）：2054-2057.
  33. 33.
    YU Y，WU X，PU J，et al.Lycium barbarum polysaccharide protects against oxygen glucose deprivation/reoxygenation-induced apoptosis and autophagic cell death via the PI3K/Akt/mTOR signaling pathway in primary cultured hippocampal neurons［J］.Biochem Biophys Res Commun，2018，495（1）：1187-1194.
  34. 34.
    LI P，YANG J，MA Y M，et al.Lycium barbarum glycopeptide attenuates cerebral ischemia/reperfusion injury in hyperglycemic rats through inhibition of ferroptosis［J］.Chin Pharmacol Bull，2023，39（11）：2043-2049.
  35. 35.
    QIU Z H，MA Y P，MA C S，et al.Lycium barbarum polysaccharide inhibits iron death through SLC7A11/GPX4 pathway to reduce cerebral ischemia-reperfusion injury in mice［J］.Chin J Neuroanat，2024，40（5）：607-612.
  36. 36.
    YE M，MOON J，YANG J，et al.The standardized Lycium chinense fruit extract protects against Alzheimer's disease in 3×Tg-AD mice［J］.J Ethnopharmacol，2015，172：85-90.
  37. 37.
    HU X Y，QU Y D，CHU Q B，et al.Investigation of the neuroprotective effects of Lycium barbarum water extract in apoptotic cells and Alzheimer's disease mice［J］.Mol Med Rep，2018，17（3）：3599-3606.
  38. 38.
    MENG J，LV Z Y，GUO M M，et al.A Lycium barbarum extract inhibits β-amyloid toxicity by activating the antioxidant system and mtUPR in a Caenorhabditis elegans model of Alzheimer's disease［J］.FASEB J，2022，36（2）：e22156.
  39. 39.
    BAI X L，LUO Y J，FAN W Q，et al.Neuroprotective effects of Lycium barbarum fruit extract on Pink1（B9）drosophila melanogaster genetic model of Parkinson's disease［J］.Plant Foods Hum Nutr，2023，78（1）：68-75.
  40. 40.
    LIU J F，MENG J，DU J H，et al.Preparative separation of flavonoids from goji berries by mixed-mode macroporous adsorption resins and effect on a β-expressing and anti-aging genes［J］.Molecules，2020，25（15）：3511.
  41. 41.
    SCHELTENS P，DE STROOPER B，KIVIPELTO M，et al.Alzheimer's disease［J］.Lancet，2021，397（10284）：1577-1590.
  42. 42.
    ITOH S G， YAGI-UTSUMI M， KATO K， et al. Key residue for aggregation of amyloid-beta peptides［J］. ACS Chem Neurosci， 2022，13（22）：3139-3151.
  43. 43.
    RAJESH Y，KANNEGANTI T D.Innate immune cell death in neuroinflammation and alzheimer's disease［J］.Cells，2022，11（12）：1885.
  44. 44.
    ISING C，VENEGAS C，ZHANG S S，et al.NLRP3 inflammasome activation drives tau pathology［J］.Nature，2019，575（7784）：669-673.
  45. 45.
    LAURETTI E， DINCER O， PRATICO D. Glycogen Synthase kinase-3 signaling in Alzheimer's disease［J］. Biochim Biophys Acta Mol Cell Res， 2020，1867（5）：118664.
  46. 46.
    BAI R R，GUO J N，YE X Y，et al.Oxidative stress：The core pathogenesis and mechanism of Alzheimer's disease［J］.Ageing Res Rev，2022，77：101619.
  47. 47.
    SHI L，YU X T，LI H，et al.D-chiro-inositol increases antioxidant capacity and longevity of caenorhabditis elegans via activating Nrf-2/SKN-1 and FoxO/DAF-16［J］.Exp Gerontol，2023，175：112145.
  48. 48.
    ZHENG Q，LU Y，YU D H，et al.DIA proteomics reveals mechanism of acanthopanacis senticosi radix et rhizoma seu caulis extract in treating α-Syn transgenic Parkinson's disease in mice［J］.Chin J Exp Tradit Med Form.2025，31（8）：40-50.
  49. 49.
    LI Y N，XIA Y J，YIN S，et al.Targeting microglial α-Synuclein/TLRs/NF-κB/NLRP3 inflammasome axis in Parkinson's disease［J］.Front Immunol，2021，12：719807.
  50. 50.
    IMBRIANI P，MARTELLA G，BONSI P，et al.Oxidative stress and Synaptic dysfunction in rodent models of Parkinson's disease［J］.Neurobiol Dis，2022，173：105851.
  51. 51.
    LI W，FU Y H，HALLIDAY G M，et al.PARK genes link mitochondrial dysfunction and alpha-Synuclein pathology in sporadic parkinson's disease［J］.Front Cell Dev Biol，2021，9：612476.
  52. 52.
    PALIKARAS K，LIONAKI E，TAVERNARAKIS N.Coordination of mitophagy and mitochondrial biogenesis during ageing in C.elegans［J］.Nature，2015，521（7553）：525-528.
  53. 53.
    TERRONE G，BALOSSO S，PAULETTI A，et al.Inflammation and reactive oxygen species as disease modifiers in epilepsy［J］.Neuropharmacology，2020，167：107742.
  54. 54.
    DING Y Q，YUAN H M，CHEN X，et al.Progress in modern medical treatment of depression［J］.West Med，2024，36（4）：614-618.
  55. 55.
    MARTIN C R，OSADCHIY V，KALANI A，et al.The brain-gut-microbiome axis［J］.Cell Mol Gastroenterol Hepatol，2018，6（2）：133-148.
  56. 56.
    ZHANG P J，LI H H，ZHU L Q，et al.The influence on the behavior of chronic psychological stress in rats by sports exercise and Ningxia medlar［J］.J North Sichuan Med Coll，2014，29（1）：10-15.
  57. 57.
    LIANG X，TANG J，CHAO F L，et al.Exercise improves depressive symptoms by increasing the number of excitatory Synapses in the hippocampus of CUS-Induced depression model rats［J］.Behav Brain Res，2019，374：112115.
  58. 58.
    CHANG J，YANG H M，SHAN X Q，et al.Bergamot essential oil improves CUMS-induced depression-like behaviour in rats by protecting the plasticity of hippocampal neurons［J］.J Cell Mol Med，2024，28（8）：e18178.
  59. 59.
    YU X D，ZHU Y，SUN Q X，et al.Distinct serotonergic pathways to the amygdala underlie separate behavioral features of anxiety［J］.Nat Neurosci，2022，25（12）：1651-1663.
  60. 60.
    DANG R Z，WANG M Y，LI X H，et al.Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway［J］.J Neuroinflammation，2022，19（1）：41.
  61. 61.
    JOLUGBO P，ARIENS R A S.Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke［J］.Stroke，2021，52（3）：1131-1142.
  62. 62.
    XU D D，KONG T T，SHAO Z Q，et al.Orexin-a alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-κB and MAPK signaling pathways in cerebral ischemia/reperfusion injury［J］.Biochim Biophys Acta BBA Mol Basis Dis，2021，1867（11）：166230.
  63. 63.
    ZHAO N，GAO Y H，JIA H T，et al.Anti-apoptosis effect of traditional Chinese medicine in the treatment of cerebral ischemia-reperfusion injury［J］.Apoptosis，2023，28（5/6）：702-729.
  64. 64.
    HASHIDATE-YOSHIDA T，HARAYAMA T，HISHIKAWA D，et al.Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport［J］.Elife，2015，4：e06328.
  65. 65.
    DING S Y，DUANMU X Y，XU L S，et al.Ozone pretreatment alleviates ischemia reperfusion injury-induced myocardial ferroptosis by activating the Nrf2/Slc7a11/Gpx4 axis［J］.Biomed Pharmacother，2023，165：115185.
  66. 66.
    LI Y R，FAN H J，CHAI Z，et al.Effects of Wuzi Yanzong pill on behavior and oxidative stress in Parkinson's disease mice［J］.Chin J Tradit Chin Med Pharm，2020，35（6）：2795-2799.
  67. 67.
    PAN T，XIAO Q，FAN H J，et al.Effect and possible mechanism of Wuzi Yanzong pill on motor function of neurons in Parkinson's disease mice［J］.Med J Chin People's Liberation Army，2024，49（5）：550-556.
  68. 68.
    LI Y R，FAN H J，CHAI Z，et al.Neuroprotective and anti-inflammatory effects of Wuzi Yanzong pills on Parkinson's disease mice［J］.Chin J Tradit Chin Med Pharm，2020，35（7）：3623-3626.
  69. 69.
    ISHII T，WARABI E，MANN G E.Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis［J］.Free Radic Biol Med，2019，133：169-178.
  70. 70.
    SUN X，LIANG J Q，HE J C，et al.Neurotrophic factors and the regeneration of dopaminergic neurons in Parkinson's disease［J］.Chin J Gerontol，2020，40（13）：2904-2908.
  71. 71.
    HANG W，FAN S J，LI Y R，et al.Effect of Wuzi Yanzong pill on neurotrophic factors and apoptosis in brain of mice with Parkinson's disease［J］.Med J Chin People's Liberation Army，2023，48（2）：168-174.
  72. 72.
    PALASZ E，WYSOCKA A，GASIOROWSKA A，et al.BDNF as a promising therapeutic agent in Parkinson's disease［J］.Int J Mol Sci，2020，21（3）：1170.
  73. 73.
    KANG S S，WU Z R，LIU X，et al.Treating Parkinson's disease via activation of BDNF/TrkB signaling pathways and inhibition of delta-secretase［J］.Neurotherapeutics，2022，19（4）：1283-1297.
  74. 74.
    JIA D，TANG Y Z，ZHANG J，et al.Therapeutic effect of electroacupuncture combined with Wuzi Yanzong pill on mice with Parkinson's disease by regulating BDNF/TrkB/CREB signaling pathway［J］.World Chin Med，2024，19（14）：2098-2105.
  75. 75.
    ZHI D，XU S，ZHANG L，et al.Shenqi formula delayed Alzheimer's disease-like symptoms by Skn-1 pathway in Caernorhabditis elegans［J］.J Ethnopharmacol，2023，316：116741.
  76. 76.
    LIN Z Y，YAO M L，ZHENG G Y.Tiaobu Xinshen prescription promotes the Synthesis of Synaptic plasticity-related proteins in 5×FAD transgenic mice with alzheimer's disease by activating the PI3K/Akt/mTOR pathway［J］.Tradit Chin Drug Res Clin Pharmacol，2024，35（8）：1191-1196.
  77. 77.
    LIN Z Y，HUANG T W，HUANG J S，et al.Tiaobu Xinshen recipe（调补心肾方） improved mild cognitive impairment of alzheimer's disease patients with Xin（heart） and Shen（kidney） deficiency［J］.Chin J Integr Med，2020，26（1）：54-58.
  78. 78.
    HUANG S K.Pharmacodynamic evaluation and mechanism of Bushen Yizhi formula in treating Parkinson's disease［D］.Guangzhou：Guangzhou Univ Chin Med，2018.
  79. 79.
    CHEN Y H，YAN B，GUAN Y，et al.Effect of Erjing pills on learning and memory abilities of AD rats with kidney Yin deficiency induced by ovariectomy+D-galactose combined with Aβ1-40［J］.Tradit Chin Drug Res Clin Pharmacol，2019，30（12）：1421-1427.
  80. 80.
    HUANG L P，QIU X P，YANG X U，et al.Effect of Erjing pill on hippocampal dopaminergic function in AD rats with kidney Yin deficiency induced by ovariectomy + D-galactose combined with Aβ1-40［J］.Tradit Chin Drug Res Clin Pharmacol，2021，32（4）：479-483.
  81. 81.
    HUANG L P，LU L H，YANG X Y，et al.Effect of Erjing pills on alleviating neuroinflammation of AD rats based on TLR4/NF-κB/NLRP3 pathway and its mechanism［J］.Chin J Chin Mater Med，2023，48（3）：770-777.

Читать полностью

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website